当前位置: 首页 >> 检索结果
43. Perceived stress as a risk factor for peptic ulcers: a register-based cohort study.
作者: Ulrik Deding.;Linda Ejlskov.;Mads Phillip Kofoed Grabas.;Berit Jamie Nielsen.;Christian Torp-Pedersen.;Henrik Bøggild.
来源: BMC Gastroenterol. 2016年16卷1期140页
The association between stress and peptic ulcers has been questioned since the discovery of helicobacter pylori. This study examined whether high perceived everyday life stress was associated with an increased risk of either receiving a triple treatment or being diagnosed with a peptic ulcer.
50. No Excess Cancer Recurrence After Immunosuppressive Drugs in a Meta-analysis of Cohorts of Patients With Immune-mediated Diseases: A Mirage Related to Propensity Bias?57. Eradication of Helicobacter pylori Infection Restores ki67, p53, and Cyclin D1 Immunoreactivity in the Human Gastric Epithelium.
作者: Konstantinos Triantafyllou.;Vasilios Papadopoulos.;Theodoros Emanouil.;Paraskevas Gkolfakis.;Vasileia Damaskou.;Georgios Tziatzios.;Ioannis G Panayiotides.;Irene Vafiadis.;Spiros D Ladas.
来源: Clin Med Insights Gastroenterol. 2016年9卷73-78页
We evaluated the effect of Helicobacter pylori (HP) eradication on p53, cyclin D1 expression, and cell proliferation in gastric mucosa.
58. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.
作者: Esther Toes-Zoutendijk.;Monique E van Leerdam.;Evelien Dekker.;Frank van Hees.;Corine Penning.;Iris Nagtegaal.;Miriam P van der Meulen.;Anneke J van Vuuren.;Ernst J Kuipers.;Johannes M G Bonfrer.;Katharina Biermann.;Maarten G J Thomeer.;Harriët van Veldhuizen.;Sonja Kroep.;Marjolein van Ballegooijen.;Gerrit A Meijer.;Harry J de Koning.;Manon C W Spaander.;Iris Lansdorp-Vogelaar.; .
来源: Gastroenterology. 2017年152卷4期767-775.e2页
After careful pilot studies and planning, the national screening program for colorectal cancer (CRC), with biennial fecal immunochemical tests (FITs), was initiated in The Netherlands in 2014. A national information system for real-time monitoring was developed to allow for timely evaluation. Data were collected from the first year of this screening program to determine the importance of planning and monitoring for optimal screening program performance.
59. Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency.
作者: Jameson R Lam.;Jennifer L Schneider.;Charles P Quesenberry.;Douglas A Corley.
来源: Gastroenterology. 2017年152卷4期821-829.e1页
Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) suppress gastric acid production, which can inhibit iron absorption. However, few data exist regarding whether these medications increase the risk of clinical iron deficiency.
60. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
作者: Donna L White.;Aaron P Thrift.;Fasiha Kanwal.;Jessica Davila.;Hashem B El-Serag.
来源: Gastroenterology. 2017年152卷4期812-820.e5页
The incidence and mortality of hepatocellular carcinoma (HCC) have been reported to be plateauing in the United States. The United States has large racial, ethnic, and regional variation; we collected data from all 50 states to better analyze changes in HCC incidence in the entire United States.
|